Pages that link to "Q50547545"

The following pages link to BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer (Q50547545):

Displaying 23 items.

• Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer (Q28271817) (← links)
• Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study (Q30433040) (← links)
• Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations (Q34065253) (← links)
• Functional characterization of BRCA1 gene variants by mini-gene splicing assay (Q34508273) (← links)
• New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing (Q35600785) (← links)
• Germline BRCA1 mutations increase prostate cancer risk (Q38639522) (← links)
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control (Q36117690) (← links)
• Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review (Q37885224) (← links)
• The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise (Q38426636) (← links)
• A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer (Q42181679) (← links)
• Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members (Q46145271) (← links)
• Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer (Q46328116) (← links)
• BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway (Q48534893) (← links)
• A Danish national effort of BRCA1/2 variant classification (Q49718948) (← links)
• Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG. (Q49818524) (← links)
• DBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark (Q50547499) (← links)
• A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing (Q50552807) (← links)
• Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations (Q50553282) (← links)
• BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population. (Q50569587) (← links)
• A high frequent BRCA1 founder mutation identified in the Greenlandic population. (Q53121377) (← links)
• Identification of BRCA1-deficient ovarian cancers. (Q54384897) (← links)
• Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland. (Q54432969) (← links)
• Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank (Q92354869) (← links)